Healios K.K. (4593.T)
Healios K.K., engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
236.00+0.08%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-63.0%
The outlook
Healios K.K. currently reads as leaning bearish based on below its 50- & 200-day averages, 6% of the way from its 52-week low to high, avg target +230% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +230% vs current price
Analyst price target
~12-month · 6 analysts779.83average target+230.4% vs now
Now 236.00
Low 510.00High 1,199.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$31.86B
52-wk high
664.00
52-wk low
208.00
50-day avg
270.12
200-day avg
354.62
Trailing P/E
—